Form 4 for CSBR CHAMPIONS ONCOLOGY, INC.
Accepted 2025-11-06 00:00:00 ET · period of report 2025-10-30 · accession 0001628280-25-049954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-06 | 2025-10-30 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | +94.4K | 1.06M | +10% | +$198.3K |
| D | 2025-11-06 | 2025-10-30 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | -94.4K | 0 | -100% | -$198.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-30 | M | A | 94,405 | $2.10 | 1,056,539 | D | — | — | |
| 2 | Derivative | Option to purchase Common Stock | 2025-10-30 | M | D | 94,405 | $2.10 | 0 | D | $2.10 · — to 2025-11-01 | 94,405 Common Stock | (F1) 70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016. |